These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6883358

  • 1. Vindesine in the treatment of malignant mesothelioma: a phase II study.
    Kelsen D, Gralla R, Cheng E, Martini N.
    Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
    [Abstract] [Full Text] [Related]

  • 2. Vindesine in the treatment of esophageal carcinoma: a phase II study.
    Kelsen DP, Bains M, Cvitkovic E, Golbey R.
    Cancer Treat Rep; 1979 Sep; 63(11-12):2019-21. PubMed ID: 526935
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vindesine. A phase II trial in advanced breast cancer patients.
    Robins HI, Tormey DC, Skelley MJ, Falkson G, Crowley JJ, Ramirez G, Falkson H.
    Cancer Clin Trials; 1981 Sep; 4(4):371-5. PubMed ID: 7318120
    [Abstract] [Full Text] [Related]

  • 6. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T, Masaoka T, Shibata H, Kubota Y, Saigo K, Kusakabe H, Takubo T, Nakamura H, Yoshitake J, Ishigami S.
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of diaziquone in malignant mesothelioma.
    Eagan RT, Frytak S, Richardson RL, Creagan ET, Nichols WC.
    Cancer Treat Rep; 1986 Mar; 70(3):429. PubMed ID: 3955559
    [No Abstract] [Full Text] [Related]

  • 14. [A phase II study of vindesine for pretreated non-small cell lung cancer].
    Shimizu E, Nakamura Y, Yamasaki K, Kimura K, Inoue I, Nakahira S, Kawahito K, Tani K, Sone S, Yamashita T.
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2532-6. PubMed ID: 3039921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma.
    Stebbing J, Powles T, McPherson K, Shamash J, Wells P, Sheaff MT, Slater S, Rudd RM, Fennell D, Steele JP.
    Lung Cancer; 2009 Jan; 63(1):94-7. PubMed ID: 18486273
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Vinorelbine in patients with malignant pleural mesothelioma--a phase II study].
    Ost E, Illiger HJ.
    Strahlenther Onkol; 2001 Aug; 177(8):440-1. PubMed ID: 11544910
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of esophageal cancer with vindesine: an open trial.
    Bezwoda WR, Derman DP, Weaving A, Nissenbaum M.
    Cancer Treat Rep; 1984 May; 68(5):783-5. PubMed ID: 6722833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.